FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
-22.93%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$281M
AUM Growth
+$281M
(-24%)
Cap. Flow
-$859K
Cap. Flow
% of AUM
-0.31%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$859K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
10x Genomics
TXG
$1.74B
| $255M | 90.72% |
1,753,528
| – | – |
|
2
Novavax
NVAX
$1.21B
| $14M | 4.96% |
67,373
| – | – |
|
|
XLRN
3
DELISTED
Acceleron Pharma Inc.
XLRN
| $7.9M | 2.81% |
45,884
| – | – |
|
|
EPZM
4
DELISTED
Epizyme, Inc
EPZM
| $4.26M | 1.51% |
832,336
-167,666
| -17% | -$859K |
|